Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 4/2011

01.08.2011 | Laboratory Investigation

Adrenal Radiofrequency Ablation in Swine: Change in Blood Pressure and Histopathologic Analysis

verfasst von: Koichiro Yamakado, Haruyuki Takaki, Katsunori Uchida, Atsuhiro Nakatsuka, Taizo Shiraishi, Kan Takeda

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate changes in blood pressure during adrenal radiofrequency ablation (RFA) and analyze histopathologic outcomes in swine adrenal glands.

Materials and Methods

Animal Care Committee approval was obtained for this study. After laparotomy, a single adrenal gland was ablated from each of six animals (six RF sessions total). An internally cooled-tip RF electrode was placed along the long axis of the adrenal gland, and RF energy was applied for 10 min in each adrenal gland. Blood pressure and heart rate were monitored, and serum epinephrine, norepinephrine, and cortisol levels were measured before, during, and after RFA. Histological study was performed using hematoxylin-eosin staining.

Results

RFA was completed according to a planned protocol in all adrenal glands. Blood pressure increased to >200 mm Hg after an increase in heart rate during all six RF sessions. Mean serum epinephrine and norepinephrine levels increased significantly during RFA. However, mean cortisol levels showed no significant increase during or after RFA. Histological studies showed adrenal cell necrosis throughout the adrenal glands in all but one pig, with the mean necrosis rate being 99.1 ± 2.3% (range 94.3–100%).

Conclusion

Adrenal RFA causes extensive adrenal cell damage and causes catecholamine-induced hypertension.
Literatur
1.
Zurück zum Zitat Livraghi T, Goldberg SN, Lazzaroni S et al (2000) Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 214(3):761–768PubMed Livraghi T, Goldberg SN, Lazzaroni S et al (2000) Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 214(3):761–768PubMed
2.
Zurück zum Zitat Yamakado K, Hase S, Matsuoka T et al (2007) Radiofrequency ablation for the treatment of unrespectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 18(3):393–398PubMedCrossRef Yamakado K, Hase S, Matsuoka T et al (2007) Radiofrequency ablation for the treatment of unrespectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 18(3):393–398PubMedCrossRef
3.
Zurück zum Zitat Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR (2003) Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 226(2):417–424PubMedCrossRef Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR (2003) Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 226(2):417–424PubMedCrossRef
4.
Zurück zum Zitat Nakatsuka A, Yamakado K, Maeda M et al (2004) Radiofrequency ablation combined with bone cement injection for the treatment of bone malignancies. J Vasc Interv Radiol 15(7):707–712PubMed Nakatsuka A, Yamakado K, Maeda M et al (2004) Radiofrequency ablation combined with bone cement injection for the treatment of bone malignancies. J Vasc Interv Radiol 15(7):707–712PubMed
5.
Zurück zum Zitat Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T (2003) Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97(3):554–560PubMedCrossRef Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T (2003) Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97(3):554–560PubMedCrossRef
6.
Zurück zum Zitat Mayo-Smith WW, Dupuy DE (2004) Adrenal neoplasms: CT-guided radiofrequency ablation―Preliminary results. Radiology 231(1):225–230PubMedCrossRef Mayo-Smith WW, Dupuy DE (2004) Adrenal neoplasms: CT-guided radiofrequency ablation―Preliminary results. Radiology 231(1):225–230PubMedCrossRef
7.
Zurück zum Zitat Yamakado K, Anai H, Takaki H et al (2009) Adrenal metastasis from hepatocellular carcinoma: radiofrequency ablation combined with adrenal arterial chemoembolization in six patients. AJR Am J Roentgenol 192(6):300–305CrossRef Yamakado K, Anai H, Takaki H et al (2009) Adrenal metastasis from hepatocellular carcinoma: radiofrequency ablation combined with adrenal arterial chemoembolization in six patients. AJR Am J Roentgenol 192(6):300–305CrossRef
8.
Zurück zum Zitat Lo WK, van Sonnenberg E, Shankar S et al (2006) Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. J Vasc Interv Radiol 17(1):175–179PubMedCrossRef Lo WK, van Sonnenberg E, Shankar S et al (2006) Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. J Vasc Interv Radiol 17(1):175–179PubMedCrossRef
9.
Zurück zum Zitat Chini EN, Brown MJ, Farrell MA, Charboneau JW (2004) Hypertensive crisis in a patient undergoing percutaneous radiofrequency ablation of an adrenal mass under general anesthesia. Anesth Analg 99(6):1867–1869PubMedCrossRef Chini EN, Brown MJ, Farrell MA, Charboneau JW (2004) Hypertensive crisis in a patient undergoing percutaneous radiofrequency ablation of an adrenal mass under general anesthesia. Anesth Analg 99(6):1867–1869PubMedCrossRef
10.
Zurück zum Zitat Arima K, Yamakado K, Suzuki R et al (2007) Image-guided radiofrequency ablation for adrenocortical adenoma with cushing syndrome: outcomes after mean follow-up of 33 months. Urology 70(3):407–411PubMedCrossRef Arima K, Yamakado K, Suzuki R et al (2007) Image-guided radiofrequency ablation for adrenocortical adenoma with cushing syndrome: outcomes after mean follow-up of 33 months. Urology 70(3):407–411PubMedCrossRef
11.
Zurück zum Zitat Al-Shaikh AA, Al-Rawas MM, Al-Asnag MA (2004) Primary hyperaldosteronism treated by radiofrequency ablation. Saudi Med J 25(11):1711–1714PubMed Al-Shaikh AA, Al-Rawas MM, Al-Asnag MA (2004) Primary hyperaldosteronism treated by radiofrequency ablation. Saudi Med J 25(11):1711–1714PubMed
12.
Zurück zum Zitat Johnson SP, Bagrosky BM, Mitchell EL, McIntyre RC Jr, Grant NG (2008) CT-guided radiofrequency ablation of an aldosterone-secreting primary adrenal tumor in a surgically unfit patient. J Vasc Interv Radiol 19(7):1115–1117PubMedCrossRef Johnson SP, Bagrosky BM, Mitchell EL, McIntyre RC Jr, Grant NG (2008) CT-guided radiofrequency ablation of an aldosterone-secreting primary adrenal tumor in a surgically unfit patient. J Vasc Interv Radiol 19(7):1115–1117PubMedCrossRef
13.
Zurück zum Zitat Onik G, Onik C, Medary I et al (2003) Life-threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation. AJR Am J Roentgenol 181(2):495–497PubMed Onik G, Onik C, Medary I et al (2003) Life-threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation. AJR Am J Roentgenol 181(2):495–497PubMed
14.
Zurück zum Zitat Keeling AN, Sabharwal T, Allen MJ, Hegarty NJ, Adam A (2009) Hypertensive crisis during radiofrequency ablation of the adrenal gland. J Vasc Interv Radiol 20(7):990–991PubMedCrossRef Keeling AN, Sabharwal T, Allen MJ, Hegarty NJ, Adam A (2009) Hypertensive crisis during radiofrequency ablation of the adrenal gland. J Vasc Interv Radiol 20(7):990–991PubMedCrossRef
15.
Zurück zum Zitat Itoh T, Orba Y, Takei H et al (2002) Immunohistochemical detection of hepatocellular carcinoma in the setting of ongoing necrosis after radiofrequency ablation. Mod Pathol 15(2):110–115PubMedCrossRef Itoh T, Orba Y, Takei H et al (2002) Immunohistochemical detection of hepatocellular carcinoma in the setting of ongoing necrosis after radiofrequency ablation. Mod Pathol 15(2):110–115PubMedCrossRef
16.
Zurück zum Zitat Holzbauer M, Newport HM (1969) Adrenal secretion rates and adrenal tissue concentrations of pregnenolone, progesterone, 11 beta OH-androstenedione and some other steroids in young pigs and dogs. J Physiol 200(3):821–848PubMed Holzbauer M, Newport HM (1969) Adrenal secretion rates and adrenal tissue concentrations of pregnenolone, progesterone, 11 beta OH-androstenedione and some other steroids in young pigs and dogs. J Physiol 200(3):821–848PubMed
17.
Zurück zum Zitat Sillence MN, Etherton TD (1989) Chronic effects of recombinant porcine growth hormone on adrenal weight and activity in pigs. J Anim Sci 67(7):1740–1743PubMed Sillence MN, Etherton TD (1989) Chronic effects of recombinant porcine growth hormone on adrenal weight and activity in pigs. J Anim Sci 67(7):1740–1743PubMed
18.
Zurück zum Zitat Barrett KE, Barman SM, Boitano S, Brooks HL (2010) The adrenal medulla and adrenal cortex. In: Weitz M, Brown M (eds) Ganong’s review of medical physiology, 23rd edn. McGraw-Hill, New York, NY, pp 337–361 Barrett KE, Barman SM, Boitano S, Brooks HL (2010) The adrenal medulla and adrenal cortex. In: Weitz M, Brown M (eds) Ganong’s review of medical physiology, 23rd edn. McGraw-Hill, New York, NY, pp 337–361
19.
Zurück zum Zitat Atwell TD, Wass CT, Charboneau JW, Callstrom MR, Farrell MA, Sengupta S (2006) Malignant hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol 17(3):573–575PubMedCrossRef Atwell TD, Wass CT, Charboneau JW, Callstrom MR, Farrell MA, Sengupta S (2006) Malignant hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol 17(3):573–575PubMedCrossRef
20.
Zurück zum Zitat Sudheendra D, Wood BJ (2006) Appropriate premedication risk reduction during adrenal ablation. J Vasc Interv Radiol 17(8):1367–1368PubMedCrossRef Sudheendra D, Wood BJ (2006) Appropriate premedication risk reduction during adrenal ablation. J Vasc Interv Radiol 17(8):1367–1368PubMedCrossRef
21.
Zurück zum Zitat Fransson BA, Keegan RD, Ragle CA, Haldorson GJ, Greene SA (2009) Hemodynamic changes during laparoscopic radiofrequency ablation of normal adrenal tissue in dogs. Vet Surg 38(4):490–497PubMedCrossRef Fransson BA, Keegan RD, Ragle CA, Haldorson GJ, Greene SA (2009) Hemodynamic changes during laparoscopic radiofrequency ablation of normal adrenal tissue in dogs. Vet Surg 38(4):490–497PubMedCrossRef
22.
Zurück zum Zitat Funder JW, Carey RM, Fardella C et al (2008) Endocrine society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(9):3266–3281PubMedCrossRef Funder JW, Carey RM, Fardella C et al (2008) Endocrine society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(9):3266–3281PubMedCrossRef
23.
Zurück zum Zitat Stowasser M (2009) Update in primary aldosteronism. J Clin Endocrinol Metab 94(10):3623–3630PubMedCrossRef Stowasser M (2009) Update in primary aldosteronism. J Clin Endocrinol Metab 94(10):3623–3630PubMedCrossRef
24.
Zurück zum Zitat Rossi GP, Seccia TM, Pessina AC (2008) Primary aldosteronism―part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 21(4):447–454PubMed Rossi GP, Seccia TM, Pessina AC (2008) Primary aldosteronism―part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 21(4):447–454PubMed
25.
Zurück zum Zitat Noguchi M, Earashi M, Fujii H, Yokoyama K, Harada K, Tsuneyama K (2006) Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol 93(2):120–128PubMedCrossRef Noguchi M, Earashi M, Fujii H, Yokoyama K, Harada K, Tsuneyama K (2006) Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol 93(2):120–128PubMedCrossRef
26.
Zurück zum Zitat Kurosumi M, Akashi-Tanaka S, Akiyama F et al (2008) Committee for production of histopathological criteria for assessment of therapeutic response of Japanese Breast Cancer Society. Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer 15(1):5–7PubMedCrossRef Kurosumi M, Akashi-Tanaka S, Akiyama F et al (2008) Committee for production of histopathological criteria for assessment of therapeutic response of Japanese Breast Cancer Society. Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer 15(1):5–7PubMedCrossRef
Metadaten
Titel
Adrenal Radiofrequency Ablation in Swine: Change in Blood Pressure and Histopathologic Analysis
verfasst von
Koichiro Yamakado
Haruyuki Takaki
Katsunori Uchida
Atsuhiro Nakatsuka
Taizo Shiraishi
Kan Takeda
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 4/2011
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-010-0078-6

Weitere Artikel der Ausgabe 4/2011

CardioVascular and Interventional Radiology 4/2011 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.